摘要
目的探讨经尿道等离子双极电切(PKVP)治疗前列腺增生症(BPH)的安全性与有效性。方法2003年1月至2006年12月应用 PKVP 治疗 BPH 患者180例。结果切除前列腺组织重量(52.4±26.8)g;手术时间(61.2±32.8)min;出血量(70.1±46.3)ml;无电切综合征(TURS)和闭孔神经反射发生。术后随访1~25个月,最大尿流率(Qmax)由术前的(6.2±4 1)ml/s 升高到术后的(21.2±4.6)ml/s;国际前列腺症状评分(IPSS)由(25.6±4.8)分降低至(6.8±2.6)分;剩余尿量由(67.8±27.3)ml 减少至(17.5±7.3)ml;生活质量评分(QOL)由术前的(5.1±1.5)下降至(1.8±0.5),手术前后比较差异有统计学意义(P<0.05)。结论 PKVP 具有安全性高、并发症少、前列腺切尽率高、疗效确切等优点。
Objective To investigate the safety and efficacy of transurethral plasmakinetic vaporization of prostate(PKVP) in treating benign prostatic hyperplasia. Methods Totally 180 BPH patients were treated with PKVP from January 2003 to December 2006. Results The weight of the resected prostatic tissue was (52.4± 26.8)g,operating period was (61.2± 32.8) minutes,and the amount of bleeding was (70. 1± 46.3)ml. No transurethral resection syndrome(TURS) and obturator nerve reflex was observed. The patients were followed up for 1- 25 months postoperatively, and the maximum urine flow(Qmax) was increased from (6.2± 4.1 )ml/s preoperatively to (21.2± 4.6) ml/s postoperatively; the international prostate symptom score (IPSS) was decreased from (25.6± 4.8) points to (6.8± 2.6) points; the residual urine volume was reduced from ( 67.8±27,3) m[ to ( 17.5 ±7.3) ml; the quality of life(QOL) score was decreased from (5.1± 1.5 ) to ( 1.8 ± 0.5 ), and there were significant differences before and after operation(P 〈 0.05). Conclusion PKVP has the advantages of high safety, fewer complications, high resection rate of prostate, and certain efficacy.
出处
《中国基层医药》
CAS
2007年第7期1070-1071,共2页
Chinese Journal of Primary Medicine and Pharmacy
关键词
前列腺增生症
等离子双极电切术
经尿道前列腺切除术
Prostatic hyperplasia
Plasmakinetic vaporization of prostate
Transurethral prostatectomy